Iriflophenone 3-C-glucoside
CAS No. 104669-02-5
Iriflophenone 3-C-glucoside ( Iriflophenone 3-C-β-D-glucopyranoside )
Catalog No. M23258 CAS No. 104669-02-5
Iriflophenone 3-C-glucoside,has antioxidant activity,isolated from Cyclopia genistoides.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 237 | In Stock |
|
10MG | 354 | In Stock |
|
25MG | 593 | In Stock |
|
50MG | 836 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIriflophenone 3-C-glucoside
-
NoteResearch use only, not for human use.
-
Brief DescriptionIriflophenone 3-C-glucoside,has antioxidant activity,isolated from Cyclopia genistoides.
-
DescriptionIriflophenone 3-C-glucoside,has antioxidant activity,isolated from Cyclopia genistoides.
-
SynonymsIriflophenone 3-C-β-D-glucopyranoside
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number104669-02-5
-
Formula Weight408.4
-
Molecular FormulaC19H20O10
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESO=C(C1=C(O)C=C(O)C([C@H]2[C@@H]([C@H]([C@@H]([C@@H](CO)O2)O)O)O)=C1O)C3=CC=C(O)C=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Malherbe CJ, et al. Iriflophenone-3-C-glucoside from Cyclopia genistoides: isolation and quantitative comparison of antioxidant capacity with mangiferin and isomangiferin using on-line HPLC antioxidant assays. J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Mar 1;951-952:164-71.
molnova catalog
related products
-
GNF351
GNF351 is a full antagonist of the aryl hydrocarbon receptor (AHR)with the capacity to inhibit both DRE-dependent and -independent activity.?GNF351 is minimal toxicity in mouse or human keratinocytes.?
-
F1324 acetate
F1324 acetate is an efficient, high-affinity b-cell lymphoma inhibitor with IC50 of 1 nM.
-
Isocorynoxeine
Isocorynoxeine shows the effects of lowering blood pressure, vasodilatation, and protection against ischemia-induced neuronal damage.